Clinical Trial Update: 5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative and postoperative radiation with 5-FU and aflibercept for stage II/III rectal cancer; results have been posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Zaltrap (ramucirumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-07